Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants

  • Koh, Ji Won (Department of Pediatrics, Dankook University College of Medicine) ;
  • Kim, Jong-Wan (Institute of Tissue Regeneration Engineering (ITREN), Dankook University) ;
  • Chang, Young Pyo (Department of Pediatrics, Dankook University College of Medicine)
  • Received : 2018.01.15
  • Accepted : 2018.06.11
  • Published : 2018.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To investigate the effectiveness of transient intubation for surfactant administration and extubated to nasal continuous positive pressure (INSURE) for treatment of respiratory distress syndrome (RDS) and to identify the factors associated with INSURE failure in extremely premature infants. Methods: Eighty-four infants with gestational age less than 28 weeks treated with surfactant administration for RDS for 8 years were included. Perinatal and neonatal characteristics were retrospectively reviewed, and major pulmonary outcomes such as duration of mechanical ventilation (MV) and bronchopulmonary dysplasia (BPD) plus death at 36-week postmenstrual age (PMA) were compared between INSURE (n=48) and prolonged MV groups (n=36). The factors associated with INSURE failure were determined. Results: Duration of MV and the occurrence of BPD at 36-week PMA were significantly lower in INSURE group than in prolonged MV group (P<0.05), but BPD plus death at 36-week PMA was not significantly different between the 2 groups. In a multivariate analysis, a reduced duration of MV was only significantly associated with INSURE (P=0.001). During the study period, duration of MV significantly decreased over time with an increasing rate of INSURE application (P<0.05), and BPD plus death at 36-week PMA also tended to decrease over time. A low arterial-alveolar oxygen tension ratio (a/APO2 ratio) was a significant predictor for INSURE failure (P=0.001). Conclusion: INSURE was the noninvasive ventilation strategy in the treatment of RDS to reduce MV duration in extremely premature infants with gestational age less than 28 weeks.

Keywords

References

  1. Rodriguez RJ. Management of respiratory distress syndrome: an update. Respir Care 2003;48:279-86.
  2. Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev 2002;(4):CD002770.
  3. Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO. Pathogenesis of bronchopulmonary dysplasia. Respiration 2010;79:425-36. https://doi.org/10.1159/000242497
  4. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23:305-13. https://doi.org/10.1097/MOP.0b013e328346577f
  5. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update. Neonatology 2017;111:107-25. https://doi.org/10.1159/000448985
  6. Blennow M, Bohlin K. Surfactant and noninvasive ventilation. Neonatology 2015;107:330-6. https://doi.org/10.1159/000381122
  7. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
  8. Cummings JJ, Polin RA; Committee on Fetus and Newborn, American Academy of Pediatrics. Noninvasive respiratory support. Pediatrics 2016;137(1). https://doi.org/10.1542/peds.2015-3758.
  9. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5. https://doi.org/10.1056/NEJM199410203311603
  10. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007;(4):CD003063.
  11. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007;27:422-7. https://doi.org/10.1038/sj.jp.7211754
  12. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004;113:e560-3. https://doi.org/10.1542/peds.113.6.e560
  13. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005;25:703-8. https://doi.org/10.1038/sj.jp.7211381
  14. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010;125:e1402-9. https://doi.org/10.1542/peds.2009-2131
  15. Nakhshab M, Tajbakhsh M, Khani S, Farhadi R. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study. Pediatr Neonatol 2015;56:88-94. https://doi.org/10.1016/j.pedneo.2014.05.006
  16. Isayama T, Chai-Adisaksopha C, McDonald SD. Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2015;169:731-9. https://doi.org/10.1001/jamapediatrics.2015.0510
  17. Brix N, Sellmer A, Jensen MS, Pedersen LV, Henriksen TB. Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study. BMC Pediatr 2014;14:155. https://doi.org/10.1186/1471-2431-14-155
  18. Cherif A, Hachani C, Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. Am J Perinatol 2008;25:647-52. https://doi.org/10.1055/s-0028-1090590
  19. Dani C, Corsini I, Poggi C. Risk factors for intubation-surfactantextubation (INSURE) failure and multiple INSURE strategy in preterm infants. Early Hum Dev 2012;88 Suppl 1:S3-4.
  20. Najafian B, Saburi A, Fakhraei SH, Afjeh A, Eghbal F, Noroozian R. Predicting factors of INSURE failure in low birth-weight neonates with respiratory distress syndrome: a logistic regression model. Iran J Neonatol 2014;5:30-4.
  21. Doyle DJ. Arterial/alveolar oxygen tension ratio: a critical appraisal. Can Anaesth Soc J 1986;33:471-4. https://doi.org/10.1007/BF03010973
  22. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. https://doi.org/10.1164/ajrccm.163.7.2011060
  23. Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL, et al. Delivery room continuous positive airway pressure/positive endexpiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 2004;114:651-7. https://doi.org/10.1542/peds.2004-0394
  24. Alallah J. Early CPAP versus surfactant in extremely preterm infants. J Clin Neonatol 2012;1:12-3. https://doi.org/10.4103/2249-4847.92233
  25. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970-9. https://doi.org/10.1056/NEJMoa0911783
  26. Seong IC, Shin YS, Chang YP. Prophylactic administration of surfactant with nasal continuous positive airway pressure in preterm infants with gestational age less than 30 weeks. J Korean Soc Neonatol 2012;19:253-61. https://doi.org/10.5385/jksn.2012.19.4.253
  27. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009;123:137-42. https://doi.org/10.1542/peds.2007-3501
  28. Dani C, Corsini I, Bertini G, Fontanelli G, Pratesi S, Rubaltelli FF. The INSURE method in preterm infants of less than 30 weeks' gestation. J Matern Fetal Neonatal Med 2010;23:1024-9. https://doi.org/10.3109/14767050903572174
  29. Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011;378:1627-34. https://doi.org/10.1016/S0140-6736(11)60986-0
  30. Gopel W, Kribs A, Hartel C, Avenarius S, Teig N, Groneck P, et al. Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr 2015;104:241-6. https://doi.org/10.1111/apa.12883
  31. Dargaville PA, Ali SKM, Jackson HD, Williams C, De Paoli AG. Impact of minimally invasive surfactant therapy in preterm infants at 29-32 weeks gestation. Neonatology 2018;113:7-14. https://doi.org/10.1159/000480066
  32. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013;131:e502-9. https://doi.org/10.1542/peds.2012-0603
  33. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr 2014;168:901-8. https://doi.org/10.1001/jamapediatrics.2014.1148

Cited by

  1. History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea vol.34, pp.25, 2018, https://doi.org/10.3346/jkms.2019.34.e175